Skip to Main Content

Paper Details

Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib).
Clin Cancer Res
37
2022
Author NameAffiliation
Maha HussainRobert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
Fred SaadCentre Hospitalier de l'Universite de Montreal/CRCHUM
Joaquin MateoVall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital
Niven MehraRadboud University Medical Center
Craig Gedye
Alexander Kohlmann
Johann S de BonoThe Institute of Cancer Research and Royal Marsden Hospital
  • 1 - 7

Datasets

Release 1.2